TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF DRY EYE DISEASE AND EYE INFLAMMATION
4.2.2 RISING PREFERENCE FOR PRESERVATIVE-FREE PRODUCTS
4.3 RESTRAINTS
4.3.1 SIDE-EFFECTS AND ALLERGIC REACTIONS
4.4 OPPORTUNITIES
4.4.1 ADVANCEMENT IN DIAGNOSTICS FOR DRY EYE DISEASE
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION AND SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE ARTIFICIAL TEARS MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON MANUFACTURERS
5.4 PRICING ANALYSIS
6 GLOBAL ARTIFICIAL TEARS MARKET, BY TYPE
6.1 OVERVIEW
6.2 POLYETHYLENE GLYCOL
6.3 PROPYLENE GLYCOL
6.4 CELLULOSE
6.5 GLYCERIN
6.6 OTHERS
7 GLOBAL ARTIFICIAL TEARS MARKET, BY DELIVERY MODE
7.1 OVERVIEW
7.2 EYE DROPS
7.3 OINTMENTS
7.4 SPRAYS
8 GLOBAL ARTIFICIAL TEARS MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 DRY EYE SYNDROME
8.3 ALLERGIES AND INFECTIONS
8.4 OTHERS
9 GLOBAL ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 HOSPITAL PHARMACIES
9.3 DRUG STORES
9.4 RETAIL PHARMACIES
9.5 ONLINE PHARMACIES
10 GLOBAL ARTIFICIAL TEARS MARKET, BY REGION
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 UK
10.3.3 FRANCE
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 AUSTRALIA
10.4.5 SOUTH KOREA
10.4.6 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD
10.5.1 MIDDLE EAST
10.5.2 AFRICA
10.5.3 LATIN AMERICA
11 COMPETITIVE LANDSCAPE
11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.7.1 PRODUCT LAUNCH
11.7.2 COLLABORATION
11.7.3 AGREEMENT
11.7.4 ACQUISITION
11.7.5 PARTNERSHIP
11.8 MAJOR PLAYERS FINANCIAL MATRIX
11.8.1 SALES (USD BILLION), 2022
11.8.2 R&D (USD BILLION), 2022
12 COMPANY PROFILES
12.1 JOHNSON AND JOHNSON VISION CARE
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 ALLERGAN PLC
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 PRODUCTS OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 KEY STRATEGIES
12.3 ALCON PLC
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 KEY STRATEGIES
12.4 BAUSCH & LOMB INCORPORATED
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 KEY STRATEGIES
12.5 SANTEN, INC.
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 URSAPHARM ARZNEIMITTEL GMBH
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 KEY STRATEGIES
12.7 ROHTO PHARMACEUTICAL CO., LTD.
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 KEY STRATEGIES
12.8 SIMILASAN CORPORATION
12.8.1 COMPANY OVERVIEWS
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 KEY STRATEGIES
12.9 OCUSOFT
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 KEY STRATEGIES
12.10 NICOX
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
13.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 4 GLOBAL ARTIFICIAL TEARS MARKET, FOR POLYETHYLENE GLYCOL, BY REGION, 2019–2032 (USD BILLION)
TABLE 5 GLOBAL ARTIFICIAL TEARS MARKET, FOR PROPYLENE GLYCOL, BY REGION, 2019–2032 (USD BILLION)
TABLE 6 GLOBAL ARTIFICIAL TEARS MARKET, FOR CELLULOSE, BY REGION, 2019–2032 (USD BILLION)
TABLE 7 GLOBAL ARTIFICIAL TEARS MARKET, FOR GLYCERIN, BY REGION, 2019–2032 (USD BILLION)
TABLE 8 GLOBAL ARTIFICIAL TEARS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 9 GLOBAL ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 10 GLOBAL ARTIFICIAL TEARS MARKET, FOR EYE DROPS, BY REGION, 2019–2032 (USD BILLION)
TABLE 11 GLOBAL ARTIFICIAL TEARS MARKET, FOR OINTMENTS, BY REGION, 2019–2032 (USD BILLION)
TABLE 12 GLOBAL ARTIFICIAL TEARS MARKET, FOR SPRAYS, BY REGION, 2019–2032 (USD BILLION)
TABLE 13 GLOBAL ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 14 GLOBAL ARTIFICIAL TEARS MARKET, FOR DRY EYE SYNDROME, BY REGION, 2019–2032 (USD BILLION)
TABLE 15 GLOBAL ARTIFICIAL TEARS MARKET, FOR ALLERGIES AND INFECTIONS, BY REGION, 2019–2032 (USD BILLION)
TABLE 16 GLOBAL ARTIFICIAL TEARS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 17 GLOBAL ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 18 GLOBAL ARTIFICIAL TEARS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2019–2032 (USD BILLION)
TABLE 19 GLOBAL ARTIFICIAL TEARS MARKET, FOR DRUG STORES, BY REGION, 2019–2032 (USD BILLION)
TABLE 20 GLOBAL ARTIFICIAL TEARS MARKET, FOR RETAIL PHARMACIES, BY REGION, 2019–2032 (USD BILLION)
TABLE 21 GLOBAL ARTIFICIAL TEARS MARKET, FOR ONLINE PHARMACIES, BY REGION, 2019–2032 (USD BILLION)
TABLE 22 GLOBAL ARTIFICIAL TEARS MARKET, BY REGION, 2019–2032 (USD BILLION)
TABLE 23 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 24 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 25 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 26 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 27 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 28 US: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 29 US: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 30 US: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 31 US: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 32 CANADA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 33 CANADA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 34 CANADA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 35 CANADA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 36 EUROPE: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 37 EUROPE: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 38 EUROPE: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 39 EUROPE: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 40 EUROPE: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 41 GERMANY: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 42 GERMANY: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 43 GERMANY: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 44 GERMANY: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 45 UK: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 46 UK: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 47 UK: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 48 UK: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 49 FRANCE: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 50 FRANCE: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 51 FRANCE: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 52 FRANCE: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 53 ITALY: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 54 ITALY: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 55 ITALY: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 56 ITALY: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 57 SPAIN: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 58 SPAIN: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 59 SPAIN: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 60 SPAIN: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 61 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 62 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 63 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 64 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 65 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 66 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 67 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 68 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 69 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 70 JAPAN: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 71 JAPAN: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 72 JAPAN: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 73 JAPAN: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 74 CHINA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 75 CHINA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 76 CHINA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 77 CHINA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 78 INDIA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 79 INDIA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 80 INDIA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 81 INDIA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 82 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 83 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 84 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 85 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 86 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 87 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 88 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 89 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 90 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 91 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 92 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 93 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 94 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 95 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 96 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 97 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 98 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 99 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 100 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 101 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 102 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 103 AFRICA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 104 AFRICA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 105 AFRICA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 106 AFRICA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 107 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 108 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2032 (USD BILLION)
TABLE 109 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 110 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 111 MAJOR PLAYERS IN THE GLOBAL ARTIFICIAL TEARS MARKET
TABLE 2 MOST ACTIVE PLAYERS IN THE GLOBAL ARTIFICIAL TEARS MARKET
TABLE 3 PRODUCT LAUNCH
TABLE 4 COLLABORATION
TABLE 5 AGREEMENT
TABLE 6 ACQUISITION
TABLE 7 PARTNERSHIP
TABLE 8 JOHNSON AND JOHNSON VISION: PRODUCTS OFFERED
TABLE 9 ALLERGAN PLC: PRODUCTS OFFERED
TABLE 10 ALLERGAN PLC: KEY DEVELOPMENTS
TABLE 11 ALCON PLC: PRODUCTS OFFERED
TABLE 12 ALCON PLC: KEY DEVELOPMENTS
TABLE 13 BAUSCH & LOMB INCORPORATED: PRODUCTS OFFERED
TABLE 14 BAUSCH & LOMB INCORPORATED: KEY DEVELOPMENTS
TABLE 15 SANTEN PHARMACEUTICALS INC.: PRODUCTS OFFERED
TABLE 16 URSAPHARM ARZNEIMITTEL GMBH: PRODUCTS OFFERED
TABLE 17 URSAPHARM ARZNEIMITTEL GMBH: KEY DEVELOPMENTS
TABLE 18 ROHTO PHARMACEUTICAL CO., LTD.: PRODUCTS OFFERED
TABLE 19 ROHTO PHARMACEUTICAL CO., LTD.: KEY DEVELOPMENTS
TABLE 20 SIMILASAN CORPORATION: PRODUCTS OFFERED
TABLE 21 OCUSOFT: PRODUCTS OFFERED
TABLE 22 OCUSOFT: KEY DEVELOPMENTS
TABLE 23 NICOX: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL ARTIFICIAL TEARS MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: PROTEIN ENGINEERING MARKET
FIGURE 5 DRIVER IMPACT ANALYSIS
FIGURE 6 RESTRAINT IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL ARTIFICIAL TEARS MARKET
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: ARTIFICIAL TEARS MARKET
FIGURE 9 GLOBAL ARTIFICIAL TEARS MARKET, BY TYPE, 2022 & 2032 (USD BILLION)
FIGURE 10 GLOBAL ARTIFICIAL TEARS MARKET SHARE, BY TYPE (%), 2022
FIGURE 11 GLOBAL ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2022 & 2032 (USD BILLION)
FIGURE 12 GLOBAL ARTIFICIAL TEARS MARKET SHARE, BY DELIVERY MODE (%), 2022
FIGURE 13 GLOBAL ARTIFICIAL TEARS MARKET, BY APPLICATION, 2022 & 2032 (USD BILLION)
FIGURE 14 GLOBAL ARTIFICIAL TEARS MARKET SHARE, BY APPLICATION (%), 2022
FIGURE 15 GLOBAL ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2032 (USD BILLION)
FIGURE 16 GLOBAL ARTIFICIAL TEARS MARKET SHARE, BY DISTRIBUTION CHANNEL (%), 2022
FIGURE 17 GLOBAL ARTIFICIAL TEARS MARKET, BY REGION, 2022 & 2032 (USD BILLION)
FIGURE 18 GLOBAL ARTIFICIAL TEARS MARKET SHARE (%), BY REGION, 2022
FIGURE 19 NORTH AMERICA: ARTIFICIAL TEARS MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 20 EUROPE ARTIFICIAL TEARS MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 21 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 22 REST OF THE WORLD: ARTIFICIAL TEARS MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 23 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 24 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ARTIFICIAL TEARS MARKET
FIGURE 25 GLOBAL ARTIFICIAL TEARS MARKET: COMPETITIVE LANDSCAPE
FIGURE 26 SALES, 2021
FIGURE 27 R&D, 2021
FIGURE 28 JOHNSON AND JOHNSON VISION: SWOT ANALYSIS
FIGURE 29 ALLERGAN PLC: SWOT ANALYSIS
FIGURE 30 ALCON PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 ALCON PLC: SWOT ANALYSIS
FIGURE 32 BAUSCH & LOMB INCORPORATED: SWOT ANALYSIS
FIGURE 33 SANTEN PHARMACEUTICALS INC.: FINANCIAL OVERVIEW
FIGURE 34 SANTEN PHARMACEUTICALS INC.: SWOT ANALYSIS
FIGURE 35 NICOX: FINANCIAL OVERVIEW SNAPSHOT